BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36381109)

  • 1. Retrorsine Cooperates with Gut Microbiota to Promote Hepatic Sinusoidal Obstruction Syndrome by Disrupting the Gut Barrier.
    Xiao L; Hu L; Chu H; Chen L; Yan J; Wang W; Yang X; Zhu Q; Du F; Song Y; Chen P; Hou X; Yang L
    J Clin Transl Hepatol; 2022 Dec; 10(6):1086-1098. PubMed ID: 36381109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota-derived tryptophan metabolites alleviate liver injury via AhR/Nrf2 activation in pyrrolizidine alkaloids-induced sinusoidal obstruction syndrome.
    Shang H; Huang C; Xiao Z; Yang P; Zhang S; Hou X; Zhang L
    Cell Biosci; 2023 Jul; 13(1):127. PubMed ID: 37422682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic study of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome in rats.
    Li YH; Tai WC; Xue JY; Wong WY; Lu C; Ruan JQ; Li N; Wan TF; Chan WY; Hsiao WL; Lin G
    Chem Res Toxicol; 2015 Sep; 28(9):1715-27. PubMed ID: 26280871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of liver injury induced by a pyrrolizidine alkaloid in rats.
    Chen X; Ma J; He Y; Xue J; Song Z; Xu Q; Lin G
    Phytomedicine; 2021 Aug; 89():153595. PubMed ID: 34153877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A TMT-based shotgun proteomics uncovers overexpression of thrombospondin 1 as a contributor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
    Wang W; Chen Y; Yin Y; Wang X; Ye X; Jiang K; Zhang Y; Zhang J; Zhang W; Zhuge Y; Chen L; Peng C; Xiong A; Yang L; Wang Z
    Arch Toxicol; 2022 Jul; 96(7):2003-2019. PubMed ID: 35357534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.
    Yang XQ; Ye J; Li X; Li Q; Song YH
    World J Gastroenterol; 2019 Jul; 25(28):3753-3763. PubMed ID: 31391770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome.
    Zhang W; Liu L; Zhang M; Zhang F; Peng C; Zhang B; Chen J; Li L; He J; Xiao J; Feng Y; Wang X; Xiong A; Yang L; Zou X; Yu Y; Zhuge Y
    J Clin Transl Hepatol; 2021 Jun; 9(3):345-352. PubMed ID: 34221920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The key role of gut-liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicity.
    He Y; Ma J; Fan X; Ding L; Ding X; Zhang QY; Lin G
    Acta Pharm Sin B; 2021 Dec; 11(12):3820-3835. PubMed ID: 35024309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.
    Liu F; Rong X; Guo H; Xu D; Liu C; Meng L; Yang X; Guo T; Kan X; Song Y
    BMC Gastroenterol; 2020 Feb; 20(1):30. PubMed ID: 32019495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome.
    Gao H; Ruan JQ; Chen J; Li N; Ke CQ; Ye Y; Lin G; Wang JY
    Drug Des Devel Ther; 2015; 9():4861-8. PubMed ID: 26346783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi - Case report and literature review.
    Tan Y; Zheng S
    Open Med (Wars); 2023; 18(1):20230737. PubMed ID: 37333448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood microRNA Signatures Serve as Potential Diagnostic Biomarkers for Hepatic Sinusoidal Obstruction Syndrome Caused by
    Wang X; Zhang W; Yang Y; Chen Y; Zhuge Y; Xiong A; Yang L; Wang Z
    Front Pharmacol; 2021; 12():627126. PubMed ID: 33679405
    [No Abstract]   [Full Text] [Related]  

  • 13. Bear bile powder attenuates senecionine-induced hepatic sinusoidal obstruction syndrome in mice.
    Jiang KY; Zhang Y; Ye XL; Xiong F; Chen Y; Jia XL; Zhang YX; Yang L; Xiong AZ; Wang ZT
    Chin J Nat Med; 2022 Apr; 20(4):270-281. PubMed ID: 35487597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional metabolomics characterizes the contribution of farnesoid X receptor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
    Xiong A; Lu L; Jiang K; Wang X; Chen Y; Wang X; Zhang W; Zhuge Y; Huang W; Li L; Liao Q; Yang F; Liu P; Ding L; Wang Z; Yang L
    Arch Toxicol; 2024 May; ():. PubMed ID: 38703205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports.
    Jiang M; Wang L; Du X; Hao M; Gao P
    J Int Med Res; 2020 Sep; 48(9):300060520961916. PubMed ID: 32993424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function.
    Guo T; Li X; Yang X; Kong X; Liu H; Bai T; Xu K; Ye J; Song Y
    Sci Rep; 2019 Feb; 9(1):1231. PubMed ID: 30718698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of liver sinusoidal endothelial cell damage in the developmental process of hepatic sinusoidal obstruction syndrome: a focus on the research progress of immune inflammatory mechanisms].
    Sun R; Li T; Ren WH
    Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):279-283. PubMed ID: 38584115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
    Lin G; Wang JY; Li N; Li M; Gao H; Ji Y; Zhang F; Wang H; Zhou Y; Ye Y; Xu HX; Zheng J
    J Hepatol; 2011 Apr; 54(4):666-73. PubMed ID: 21146894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic sinusoidal obstruction syndrome caused by the ingestion of
    Cen P; Ding J; Jin J
    J Int Med Res; 2021 Apr; 49(4):300060520980649. PubMed ID: 33845617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological evaluation of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: Correlation with Drum Tower Severity Scoring.
    Li R; Li L; Cai Z; Chen J; Zhang H; Zhao S; Tu J; Sun C; Jin Y; Zhang M; Zhang F; Zhang W; Yin Q; Xu H; Han H; Li T; Zhuge Y; Xiao J
    Dig Liver Dis; 2024 Jul; 56(7):1220-1228. PubMed ID: 38151450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.